Recent News for DMAC - DiaMedica Therapeutics Inc.

Date Title
Sep 11 DiaMedica Therapeutics (DMAC) Presents At 4th Annual Dougherty & Company Institutional Investor Conference - Slideshow
Sep 6 DiaMedica Therapeutics to Present at Lake Street’s 3rd Annual Best Ideas Growth (BIG3) Conference on September 12, 2019
Sep 3 DiaMedica Therapeutics to Present at the 2019 Dougherty & Co. Institutional Investor Conference
Aug 15 Sintx Technologies leads healthcare gainers; Cytosorbents and Genetic Technologies among losers
Aug 15 The Daily Biotech Pulse: Mallinkckrodt's Terlipressin, Deciphera Offering, Sellas Reboots On Earnings
Aug 15 61 Biggest Movers From Yesterday
Aug 14 DiaMedica Therapeutics Inc. (DMAC) CEO Rick Pauls on Q2 2019 Results - Earnings Call Transcript
Aug 14 Novavax and Akari Therapeutics among healthcare gainers; DelMar Pharmaceuticals leads the losers
Aug 13 DiaMedica Therapeutics EPS beats by $0.05
Aug 13 DiaMedica Therapeutics Announces Second Quarter 2019 Financial Results and Provides Business Update
Aug 12 DiaMedica Therapeutics to Present at the 2019 Intellisight Investor Conference on August 14, 2019
Aug 8 DiaMedica Therapeutics to Report Second Quarter 2019 Financials and Provide a Business Update August 13, 2019
Jul 10 MDR, AMRX, LEVI and MFGP among midday movers
Jul 10 OncoSec Medical and Trinity Biotech among healthcare gainers; Amneal Pharmaceuticals leads the losers
Jun 21 The Daily Biotech Pulse: ContraVir's Volatile Ride Continues, Late-Stage Disappointment For Exelixis, Regeneron-Sanofi Breathe Easy
Jun 20 Microcaps mostly among midday movers
Jun 20 Arbutus Biopharma leads healthcare gainers; Verastem and Jaguar Health among losers
Jun 20 What's Pushing Nano-Cap Biotech DiaMedica's Shares Higher?
Jun 20 Mid-Morning Market Update: Markets Open Higher; Kroger Posts Upbeat Sales
Jun 20 AUY, HL among premarket gainers
Jun 20 The Daily Biotech Pulse: DiaMedica Reports Positive Data For Chronic Kidney Disease Drug, Eloxx Offering, IPO Deluge
Jun 19 DiaMedica Therapeutics Announces Interim Results from Phase 1b Trial of DM199 in Chronic Kidney Disease Participants
May 21 DiaMedica Therapeutics Announces Formation of Scientific Advisory Board for Kidney Disease
May 14 DiaMedica Therapeutics Inc. (DMAC) CEO Rick Pauls on Q1 2019 Results - Earnings Call Transcript
May 14 DiaMedica Therapeutics, Inc. to Host Earnings Call
Back to the Main DMAC Page...